Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...
Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback